Kirch W, Laskowski M, Ohnhaus E E, Aberg J
Department of Internal Medicine, Christian-Albrechts University, Kiel, FRG.
J Intern Med. 1989 Apr;225(4):237-9. doi: 10.1111/j.1365-2796.1989.tb00072.x.
The interaction between felodipine and digoxin was studied after a single oral dose and at steady state in 14 patients with congestive heart failure. Felodipine (10 mg) was randomly given as an extended release (FER) tablet in a double-blind, placebo-controlled, cross-over fashion. In addition, felodipine (10 mg) was given openly as a plain tablet, following the double-blind period. Each period lasted for 7 d. Felodipine ER did not alter the pharmacokinetics of digoxin when given as a single dose or at steady state compared with placebo. At steady state the felodipine plain tablet resulted in an 11% increase (P less than 0.05) in peak plasma concentrations of digoxin. Systolic time intervals as noninvasively measured haemodynamic parameters were not significantly altered following the felodipine ER period, while the felodipine plain tablet significantly decreased the pre-ejection/left ventricular ejection time ratio compared to placebo.
在14例充血性心力衰竭患者中,研究了非洛地平与地高辛单次口服给药后及稳态时的相互作用。非洛地平(10mg)以缓释(FER)片的形式,采用双盲、安慰剂对照、交叉方式随机给药。此外,在双盲期后,非洛地平(10mg)以普通片剂的形式开放给药。每个周期持续7天。与安慰剂相比,非洛地平缓释片单次给药或在稳态时均未改变地高辛的药代动力学。在稳态时,非洛地平普通片剂使地高辛的血浆峰浓度升高了11%(P<0.05)。作为无创测量血流动力学参数的收缩期时间间期,在非洛地平缓释片给药期后无显著改变,而与安慰剂相比,非洛地平普通片剂显著降低了射血前期/左心室射血时间比值。